论文部分内容阅读
目的探讨胺碘酮联合美托洛尔治疗心律失常的临床疗效。方法选取2014年6月—2015年6月丰县人民医院收治的心律失常患者48例,随机分为对照组与观察组,各24例。对照组患者予以美托洛尔治疗,观察组患者在对照组基础上加用胺碘酮治疗。观察两组患者临床疗效、起效时间及不良反应发生情况。结果观察组患者总有效率高于对照组,起效时间短于对照组,差异有统计学意义(P<0.05);两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论胺碘酮联合美托洛尔治疗心律失常的临床疗效显著,可缩短起效时间,且不良反应少。
Objective To investigate the clinical efficacy of amiodarone combined with metoprolol in the treatment of arrhythmia. Methods Forty-eight patients with arrhythmia admitted from June 2014 to June 2015 in Fengxian People’s Hospital were randomly divided into control group and observation group, with 24 cases in each group. Patients in the control group were treated with metoprolol. Patients in the observation group were treated with amiodarone on the basis of the control group. The clinical efficacy, onset time and adverse reactions of the two groups were observed. Results The total effective rate in the observation group was higher than that in the control group, and the onset time was shorter than that in the control group (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05) . Conclusion Amiodarone combined with metoprolol in the treatment of arrhythmia significant clinical effect, can shorten the onset time, and fewer adverse reactions.